Skip to main content
. 2020 Jul 13;20:242. doi: 10.1186/s12877-020-01642-4

Table 2.

Characteristics of participants according to sarcopenia groups

EWGSOP1 EWGSOP2
ALM/h2 + HG + GS HG + ALM/h2 + GS HG + ALM/h2 + TUG HG + ALM/h2 + SPPB STS + ALM/h2 + GS STS + ALM/h2 + TUG STS + ALM/h2 + SPPB
Prevalence 36 (12%) 22 (8%) 12 (4%) 19 (7%) 46 (16%) 24 (8%) 47 (16%)
Age (yrs) 81.5 (76, 84) 82.5 (76, 84) 83 (78.5, 84.5) 82 (76, 85) 80 (75, 84) 80.5 (76, 84) 81 (76, 85)
Sex (women), n (%) 22 (61%) 14 (64%) 7 (58%) 12 (63%) 32 (70%) 16 (67%) 32 (68%)
Weight (kg) 57.3 (50.6, 67.6) 55.3 (50, 66) 56.7 (50.1, 65.7) 55.2 (50, 66) 57.6 (51, 64.1) 56.3 (50.2, 63.5) 56 (50, 64)
Height (cm) 155 (151, 163) 154 (149, 163) 156 (151, 163) 155 (152, 163) 156 (151, 163) 157 (150, 165) 157 (152, 163)
Body Mass Index 23.79 (21.83, 26.19) 23.41 (20.81, 26.01) 23.39 (21.44, 25.61) 22.97 (20.28, 25.20) 23.26 (21.17, 26.01) 22.49 (21.45, 24.64) 23.23 (20.81, 25.20)
ALM/h2 5.42 (5.12, 5.92) 5.40 (5.12, 5.67) 5.38 (5.04, 5.58) 5.26 (5.04, 5.67) 5.22 (5.00, 5.67) 5.23 (5.02, 5.58) 5.23 (5.03, 5.83)
Falls in past year 2 (1, 2) 2 (1, 2) 2 (1, 3.5) 2 (1, 3) 2 (1, 2) 2 (1, 2.5) 2 (1, 3)
Handgrip strength (kg) 16 (12, 20) 13.5 (11, 17) 13.5 (12, 19) 12 (11, 18) 20 (15, 24) 19.5 (15, 22) 20 (14, 24)
SPPB score 5.5 (4.5, 7.0) 6 (4, 8) 4 (2.5, 6.5) 5 (4, 7) 5.5 (4, 7) 4.5 (4, 6) 6 (4, 7)
Timed Up and Go (s) 19.31 (16.71, 24.39) 19.50 (16.71, 24.39) 25.09 (22.27, 33.94) 19.77 (16.81, 25.80) 19.46 (16.71, 24.39) 25.09 (21.62, 29.92) 19.23 (15.42, 24.39)
Gait Speed (m/s) 0.54 (0.39, 0.69) 0.51 (0.38, 0.66) 0.38 (0.26, 0.61) 0.50 (0.38, 0.65) 0.56 (0.40, 0.70) 0.46 (0.33, 0.62) 0.56 (0.40, 0.71)
FES-I 36 (25.5, 48.5) 36.5 (29, 52) 50 (29, 59.5) 38 (29, 57) 37 (26, 48) 43.5 (26.5, 52.5) 36 (25, 48)

ALM/h2 Appendicular Lean Mass corrected for height squared, GS Gait speed, HG Handgrip strength, SPPB Short Physical Performance Battery, TUG Timed up and go, FES-I Falls Efficacy Scale – International